胃轻瘫患者愿意承担药物治疗风险的意愿
本研究通过问卷评估胃轻瘫患者对药物治疗风险的接受程度。103例完成问卷的患者中,为治愈症状愿意接受中位13.4%的猝死风险。自报症状严重度和胃轻瘫主要症状指数评分与风险接受意愿显著相关,焦虑则呈负相关。
要点
- 胃轻瘫患者为治愈症状愿意接受中位13.4%的猝死风险。
- 自报症状严重度和胃轻瘫主要症状指数评分越高,越愿意承担药物风险。
- 焦虑与承担药物风险的意愿呈负相关。
核心结论
- 胃轻瘫患者愿意为治愈症状接受假想药物带来的显著高风险。
- 症状严重且胃轻瘫主要症状指数评分较高的患者更愿意承担这些风险。
- 本研究首次量化胃轻瘫患者对药物相关风险的接受意愿,应有助于临床医生在复杂的胃轻瘫治疗及其风险获益中做出决策。
研究设计与样本
- 研究开发问卷评估已确诊胃轻瘫患者(症状一致、上消化道内镜正常、胃排空延迟)的用药风险承担行为。
- 问卷评估人口学特征、症状、用药、焦虑、抑郁和冲动性,并用标准参考博弈评估受访者承担药物风险的意愿。
- 共邮寄207份问卷,回收完成103份。
主要发现
- 完成问卷的103例患者中76%为女性,平均年龄48岁,胃轻瘫症状平均病程10年。
- 自报症状严重程度为重度者占52%,中度者占32%。
- 胃轻瘫患者报告,为用假想药物治愈症状,愿意接受中位13.4%的猝死风险。
- 自报胃轻瘫症状严重程度和胃轻瘫主要症状指数评分与承担胃轻瘫治疗药物相关风险的意愿增加显著相关,而焦虑与风险承担意愿呈负相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastroparesis has a significant negative impact on patients' quality of life. Only one medication is approved for gastroparesis and it is associated with a significant risk of side effects. AIM: To assess the willingness of patients to take risks associated with medications to treat gastroparesis symptoms. METHODS: We developed a questionnaire to assess medication risk-taking behaviour in patients identified as having documented gastroparesis (consistent symptoms, normal upper endoscopy, delayed gastric emptying). The survey assessed demographics, symptoms, medication use, anxiety, depression and impulsivity. A standard reference gamble evaluated respondents' willingness to take medication risks. RESULTS: Two hundred seven questionnaires were mailed to patients, 103 questionnaires were completed. Seventy-six percent were female; the mean age was 48 years; average duration of gastroparesis symptoms was 10 years. Self-reported symptom severity was severe in 52% and moderate in 32%. Gastroparesis patients reported that they would accept a median 13.4% risk of sudden death to cure their symptoms using a hypothetical medication. Self-reported gastroparesis symptom severity and Gastroparesis Cardinal Symptom Index scores correlated significantly with increased willingness to take risks associated with medications to treat gastroparesis, while anxiety was negatively associated. CONCLUSIONS: Gastroparesis patients are willing to accept markedly high risks with a hypothetical medication to cure their symptoms. Patients with severe gastroparesis symptoms and higher Gastroparesis Cardinal Symptom Index scores were more willing to take these risks. This study, the first to quantify gastroparesis patients' willingness to accept medication associated risks, should help clinicians through the complex maze of gastroparesis therapies and their associated risks and benefits.
引用
- Navas CM, Crowell MD, Lacy BE, et al. The willingness of patients with gastroparesis to take risks with medications. Aliment Pharmacol Ther. 2019. PMID: 30628106. doi:10.1111/apt.15112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。